NCT01551459 2019-10-29
SUAVE
The Clatterbridge Cancer Centre NHS Foundation Trust
Phase 2 Completed
Clinical Trials
5 trialsNCT02400385 2017-02-01
A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma
California Pacific Medical Center Research Institute
Phase 2 Withdrawn
NCT00577382 2016-12-08
SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00631618 2014-02-25
Clinical Trial of Sutent to Treat Metastatic Melanoma
California Pacific Medical Center Research Institute
Phase 2 Completed
NCT01216657 2013-06-04
Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma
Krankenhaus Nordwest
Phase 2 Terminated